ERBB2 and breast carcinoma: However, to make the story more complex, the polyubiquitination of ERBB2 was proposed to either induce proteasomal degradation of ERBB2 [38], to enable internalization and lysosome degradation [39], or to promote a selective autophagy of ERBB2 in breast cancer cells [6].